FDA Accepts Submission of New Drug BREXAFEMME That Prevents Vaginal Yeast Infections
SCYNEXIS has announced that the FDA has accepted the submission for their ibrexafungerp tablets BREXAFEMME. SCYNEXIS’s submission has been granted…
yeast infection
FDA Approves Brexafemme For Recurrent Yeast Infections
The Food and Drug Administration (FDA) has approved Brexafemme (ibrexafungerp) for a second indication for reduction in incidence of recurrent…